{"entity":{"id":"douglas-hawkins","kind":"person","name":"Douglas S. Hawkins","aka":[],"tldr":"Paediatric oncologist who chairs the world's largest childhood cancer research organisation.","summary":"Douglas Hawkins is Group Chair of the Children's Oncology Group (COG) and Professor of Pediatrics at Seattle Children's and the University of Washington, with ties to Fred Hutchinson Cancer Center. A paediatric oncologist specialising in bone and soft-tissue sarcomas, he led COG Ewing sarcoma trials and has chaired the Children's Oncology Group since 2020. His papers include a Journal of Clinical Oncology review of current management and collaborative future approaches in Ewing sarcoma and a COG report that adding vincristine and irinotecan to standard chemotherapy did not improve outcome in intermediate-risk rhabdomyosarcoma. His record links to the Euro Ewing 2012 trial.","asOf":"2026-09-08","links":[{"label":"Children's Oncology Group","url":"https://childrensoncologygroup.org"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Hawkins%20DS%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Douglas%20S.%20Hawkins"}],"tags":[],"related":[],"cancers":["sarcoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["childrens-oncology-group"],"institutions":["fred-hutch"],"pathways":[],"terms":[],"trials":["euro-ewing-2012"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Group Chair, Children's Oncology Group; Professor of Pediatrics, Seattle Children's and University of Washington","institutionId":"childrens-oncology-group","specialisms":["Paediatric sarcoma","Ewing sarcoma","Cooperative group trials"],"profiles":[{"label":"Children's Oncology Group","url":"https://childrensoncologygroup.org"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Hawkins%20DS%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Douglas%20S.%20Hawkins"}],"papers":[{"title":"Ewing Sarcoma: Current Management and Future Approaches Through Collaboration","journal":"Journal of Clinical Oncology","year":2015,"url":"https://doi.org/10.1200/JCO.2014.59.5256","doi":"10.1200/JCO.2014.59.5256"},{"title":"Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group","journal":"Journal of Clinical Oncology","year":2018,"url":"https://doi.org/10.1200/JCO.2018.77.9694","doi":"10.1200/JCO.2018.77.9694"}]},"route":"/people/douglas-hawkins/","neighbours":{"cancer":[{"id":"sarcoma","kind":"cancer","name":"Sarcomas (soft tissue, bone, GIST)","route":"/cancers/sarcoma/"}],"company":[{"id":"childrens-oncology-group","kind":"company","name":"Children's Oncology Group (COG)","route":"/companies/childrens-oncology-group/"}],"institution":[{"id":"fred-hutch","kind":"institution","name":"Fred Hutchinson Cancer Center","route":"/institutions/fred-hutch/"}],"trial":[{"id":"euro-ewing-2012","kind":"trial","name":"Euro Ewing 2012","route":"/trials/euro-ewing-2012/"}]}}